Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme (Q31861401)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

phase III clinical trial

0 references

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

author name string

Prados MD

1

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Wara WM

2

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Sneed PK

3

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

McDermott M

4

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Chang SM

5

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Rabbitt J

6

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Page M

7

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Malec M

8

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Davis RL

9

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Gutin PH

10

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Lamborn K

11

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Wilson CB

12

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Phillips TL

13

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Larson DA

14

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

71-77

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy for neoplasms of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: a comparison of short versus long intravenous dose schedules (RTOG 86-12).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of bromodeoxyuridine in glioblastoma multiforme: A A Northern California cancer center phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of alpha-difluoromethylornithine-induced polyamine depletion on the radiosensitivity of a human colon carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of recurrent gliomas with eflornithine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl)-1-nitrosourea and alpha-difluoromethylornithine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated hyperfractionated radiotherapy in 149 patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Modification of radiation-induced brain injury by alpha-difluoromethylornithine.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Microglial responses after focal radiation-induced injury are affected by alpha-difluoromethylornithine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial and pharmacokinetic study of intravenous and oral alpha-difluoromethylornithine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901458-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(00)01458-9

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31861401&oldid=1957092572"